📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy. (2014)

First Author: Lines JL

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2326-6066.cir-14-0072

PubMed Identifier: 24894088

Publication URI: http://europepmc.org/abstract/MED/24894088

Type: Journal Article/Review

Volume: 2

Parent Publication: Cancer immunology research

Issue: 6

ISSN: 2326-6066